New

From idea to ETF portfolio in minutes. Build yours now →

Advertisement
Advertisement

FXHvsPBEETF Comparison

ETF 1
FXH

First Trust Health Care AlphaDEX Fund ETF

This fund is part of
US Health Care
+0%
VS
ETF 2
PBE

Invesco Dynamic Biotechnology & Genome ETF

This fund is part of
BioTech & Genomics
+0%

First Trust Health Care AlphaDEX Fund ETF (FXH) belongs to the US Health Care segment. Invesco Dynamic Biotechnology & Genome ETF (PBE) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Health Care. FXH is more expensive with a Total Expense Ratio (TER) of 0.61%, versus 0.58% for PBE. FXH is down -1.02% year-to-date (YTD) with -$56M in YTD flows. PBE performs worse with -4.24% YTD performance, and -$4M in YTD flows. Run a side-by-side ETF comparison of FXH and PBE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

FXH vs PBE performance and flow charts

Performance

0.02.04.06.08.0%Mar 30Apr 7Apr 14Apr 21Apr 28

Cumulative Flows

-6 M-4 M-2 M0 M2 MMar 30Apr 7Apr 14Apr 21Apr 28

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 04/28/2026
1M3MYTD1Y3Y5Y
Perf.
FXH
PBE
+6.72%+2.23%
-2.22%-4.67%
-1.02%-4.24%
+14.25%+28.66%
+4.49%+25.55%
-1.02%+4.21%
Flows
FXH
PBE
+$354K+$18K
-$62M-$8M
-$56M-$4M
-$118M-$32M
-$713M-$60M
-$500M-$44M
Volatility and drawdown
3M1Y3Y5Y
Volatility
FXH
PBE
+17.09%+19.62%
+16.22%+19.88%
+15.23%+20.13%
+16.68%+22.54%
Max drawdown
FXH
PBE
-9.86%-9.36%
-12.07%-11.70%
-17.89%-22.21%
-29.40%-34.74%
Max drawdown duration
FXH
PBE
58d80d
111d112d
331d324d
1695d1540d
Trading data

Create an account to view trading data

Join for free
FXH
PBE
Last sale
4/30/2026 at 1:30 PM
$112.93
$79.58
Previous close
04/29/2026
$111.91
$78.51
Consolidated volume
04/29/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of April 29, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
FXH
PBE
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 4/30/2026 at 1:30 PM
Live
Closed
FXH
PBE
Last price
$112.93
$79.58
1D performance
+0.91%
+1.36%
AuM$870.97 M$244.25 M
E/R0.61%0.58%
Characteristics
FXH
PBE
Management strategyPassivePassive
ProviderFirst TrustInvesco
BenchmarkStrataQuant Health Care IndexDynamic Biotech & Genome Intellidex Index
N° of holdings7130
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateMay 8, 2007June 23, 2005
ESGNoNo
Advertisement
Exposure

Countries

FXH
USA
95.47%
Other
4.53%
PBE
USA
92.18%
Other
7.82%

Sectors

FXH
Health Care
93.76%
Other
6.24%
PBE
Health Care
97.59%
Other
2.41%
Advertisement

Diversification

FXH

Total weight of top 15 holdings out of 15

35.37%
PBE

Total weight of top 15 holdings out of 15

63.66%

Top 15 holdings

Data as of March 31, 2026
FXH
ACADIA HEALTHCARE COMPANY
3.83%
APELLIS PHARMACEUTICALS
2.95%
PFIZER
2.63%
BIOGEN INC
2.40%
CARDINAL HEALTH
2.37%
HCA HEALTHCARE
2.33%
INCYTE
2.19%
IONIS PHARMACEUTICALS INC
2.18%
INSMED
2.17%
UTD THERAPEUT
2.15%
MERCK & CO INC
2.11%
NATERA
2.04%
LILLY
2.04%
MEDPACE HOLDINGS INC
2.00%
AMGEN-T
1.98%
PBE
UTD THERAPEUT
6.05%
ILLUMINA
5.24%
REGENERON PHARMACEUTICALS
5.23%
ALNYLAM PHARMACEUTICALS
5.22%
BIOGEN INC
5.16%
AMGEN-T
4.99%
GILEAD SCIENCES
4.98%
INCYTE
4.89%
BIOCRYST PHARMACEUTICALS
3.66%
PROTAGONIST THERAPEUTICS INC
3.38%
TG THERAPEUTICS
3.11%
ROYALTY PHARMA
3.05%
NEUROCRINE BIOSCIENCES
2.93%
CATALYST PHARMACEUTICALS INC
2.89%
PTC THERAPEUTI/D
2.86%
Frequently asked questions about FXH and PBE

How have the FXH and PBE ETFs performed in 2026?

As of April 28, 2026, FXH is down -1.02% year-to-date (YTD), while PBE has lost -4.24%. That puts FXH better performer ahead so far this year.

Which ETF is attracting more investor money: FXH or PBE?

Year-to-date, the FXH ETF saw -$56M in flows, compared to -$4M for PBE.

Which ETF is more volatile: FXH or PBE?

Over the past year, FXH had a volatility of 16.22%, while PBE experienced 19.88%.

Which ETF is bigger: FXH or PBE?

As of April 28, 2026, FXH holds $870.97 M in assets under management (AUM), while PBE manages $244.25 M.

What sectors do the FXH and PBE ETFs invest in?

FXH leans toward sectors like Health Care. Meanwhile, PBE focuses on Health Care.

What are the top holdings of the FXH ETF and PBE ETF?

FXH top holdings include ACADIA HEALTHCARE COMPANY, APELLIS PHARMACEUTICALS and PFIZER. PBE holds in its top three: UTD THERAPEUT, ILLUMINA and REGENERON PHARMACEUTICALS.

Which ETF is more diversified: FXH or PBE?

FXH holds 75 securities with 35.37% of its assets in the top 15. PBE has 30 securities and a top 15 weight of 63.66%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder